178 related articles for article (PubMed ID: 7137960)
1. Tetrabenazine has properties of a dopamine receptor antagonist.
Login IS; Cronin MJ; MacLeod RM
Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine evidence that tetrabenazine is a dopamine antagonist.
Login IS; Cronin MJ; Harcus CT; MacLeod RM
Proc Soc Exp Biol Med; 1983 Feb; 172(2):225-31. PubMed ID: 6828467
[TBL] [Abstract][Full Text] [Related]
3. Effect of yohimbine on rat prolactin secretion.
Meltzer HY; Simonovic M; Gudelsky GA
J Pharmacol Exp Ther; 1983 Jan; 224(1):21-7. PubMed ID: 6294278
[TBL] [Abstract][Full Text] [Related]
4. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
5. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
6. The 7315a pituitary tumor is refractory to dopaminergic inhibition of prolactin release but contains dopamine receptors.
Cronin MJ; Valdenegro CA; Perkins SN; MacLeod RM
Endocrinology; 1981 Dec; 109(6):2160-6. PubMed ID: 7308146
[No Abstract] [Full Text] [Related]
7. [The effect of lithium treatment on the activity of central dopaminergic neurons].
Koyama T
Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
[TBL] [Abstract][Full Text] [Related]
9. Interactions between hypothalamic and peripheral hormones in the control of prolactin secretion.
Ferland L; Labrie F; Kelly PA; Raymond V
Fed Proc; 1980 Sep; 39(11):2917-22. PubMed ID: 7409210
[TBL] [Abstract][Full Text] [Related]
10. In vitro estrogen-like effects of 7,12-dimethylbenz(a)anthracene on anterior pituitary dopamine receptors of rats.
Pasqualini C; Bojda F; Kerdelhué B
Cancer Res; 1988 Nov; 48(22):6434-7. PubMed ID: 3141044
[TBL] [Abstract][Full Text] [Related]
11. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
Findell PR; Torkelson SM; Craig JC; Weiner RI
Mol Pharmacol; 1988 Jan; 33(1):78-83. PubMed ID: 3336350
[TBL] [Abstract][Full Text] [Related]
12. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
Cronin MJ; Reches A; MacLeod RM; Login IS
Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
[TBL] [Abstract][Full Text] [Related]
13. Effect of amantadine on prolactin secretion, pituitary DNA synthesis and 3H-spiperone binding in male estrogen-treated rats.
Krawczyk Z; Lyson K; Stawowy A; Pisarek H; Stepien H
Neuroendocrinology; 1990 Jun; 51(6):632-6. PubMed ID: 2141919
[TBL] [Abstract][Full Text] [Related]
14. [Direct effect of estradiol on the number of dopaminergic receptors in the anterior pituitary, in ovariectomized rats].
Pasqualini C; Kerdelhue B
C R Acad Sci III; 1985; 300(17):637-42. PubMed ID: 3939292
[TBL] [Abstract][Full Text] [Related]
15. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
Creese I; Sibley DR; Leff SE
Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
[TBL] [Abstract][Full Text] [Related]
16. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
17. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
Cronin MJ; Thorner MO
J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
[TBL] [Abstract][Full Text] [Related]
18. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M
Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
Hong M; Jenner P; Marsden CD
Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
[TBL] [Abstract][Full Text] [Related]
20. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.
Cronin MJ; Perkins SN; Keefer DA; MacLeod RM
Mol Cell Endocrinol; 1982 Oct; 28(2):229-46. PubMed ID: 7128925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
